Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Medicare Plan To Report Maximum Fair Prices Only For Part B Negotiated Drugs Will Advance
Oct 30 2025
•
By
Cathy Kelly
Manufacturers are watching for ASP policies in the upcoming Medicare Physician Fee Schedule final rule.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Medicare
More from Government Payers